Peptide profile · Cognitive
N-Acetyl Selank
Acetylated tuftsin analogue heptapeptide with enhanced stability and anxiolytic, nootropic, and immunomodulatory properties acting through GABAergic modulation and BDNF upregulation
Written & reviewed by Michael Carroll · Research, Peptide Initiative
Typical dose
300-900 mcg/day
Half-life
Extended compared to native Selank (~7-10 min plasma half-life); exact half-life of N-Acetyl form not published but estimated 2-3x longer
Bioavailability
Enhanced intranasal and subcutaneous bioavailability compared to native Selank due to N-acetylation protecting against aminopeptidase degradation
Molecular weight
793.9 g/mol
Evidence level
Limited human trials
01 · Compound profile
Scientific & efficacy data
Molecular formula
C35H59N11O10
Primary benefits
Calms your mind without making you drowsy or causing the dependence issues that come with traditional anxiety medications.
Boosts BDNF, a natural protein that helps your brain form new connections and strengthen memories over time.
Raises your body's natural calming chemicals called enkephalins, helping you bounce back faster from stressful situations.
Multiple research institutions
Amino acid sequence
Sequence not publicly available or proprietary02 · Dosing
How much do I take?
300-900 mcg/day · divided 2-3 times daily (100-300 mcg per dose)
Intranasal: Sprayed into the nose, where it absorbs through the nasal lining.
Bioavailability Moderate — absorbs through the nasal lining and can partly bypass the gut.
Best time to take
Administer N-Acetyl Selank nasal spray at the same time each day. Morning dosing is commonly preferred. Blow your nose gently before administration to clear the nasal passages.
With food?
N-Acetyl Selank nasal administration is not significantly affected by food. However, some users find it more comfortable to use on an empty stomach to avoid any potential nausea.
If stacking
N-Acetyl Selank should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
＋ Increase if
- +You've tolerated the current dose for the recommended period without significant side effects
- +Therapeutic goals haven't been met at the current dose level
- +Your healthcare provider recommends dose escalation based on your response
- +Lab work or clinical assessments support a higher dose
－ Decrease if
- −Side effects are bothersome or impacting daily life despite management strategies
- −You experience any signs of an adverse reaction
- −Lab results indicate the need for dose reduction
- −Your healthcare provider recommends a lower dose based on your response
✓ Signs of right dose
- ✓Therapeutic goals being met with minimal side effects
- ✓Stable and consistent response to treatment
- ✓Lab values or clinical markers trending in the right direction
- ✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
03 · Suitability
Is this right for me?
Best for anxiolytic support without the sedation, tolerance, or dependence associated with benzodiazepines & cognitive enhancement through bdnf-mediated neuroplasticity
Best for
Anxiolytic support without the sedation, tolerance, or dependence associated with benzodiazepines
N-Acetyl Selank is particularly well-suited for individuals focused on anxiolytic support without the sedation, tolerance, or dependence associated with benzodiazepines. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Cognitive enhancement through BDNF-mediated neuroplasticity
N-Acetyl Selank is particularly well-suited for individuals focused on cognitive enhancement through bdnf-mediated neuroplasticity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Stress resilience and emotional regulation in high-demand environments
N-Acetyl Selank is particularly well-suited for individuals focused on stress resilience and emotional regulation in high-demand environments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Complementary nootropic in cognitive stacks targeting multiple neurotransmitter systems
N-Acetyl Selank is particularly well-suited for individuals focused on complementary nootropic in cognitive stacks targeting multiple neurotransmitter systems. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare N-Acetyl Selank with similar peptides to find the best fit for your goals.
04 · Administration
How do I use it?
Intranasal spray · Subcutaneous injection
Reconstitution — what you need
Example
Add the recommended volume of bacteriostatic water to the N-Acetyl Selank vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.
Your dose of N-Acetyl Selank is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Technique
- 01Wash your hands thoroughly with soap and water before handling supplies
- 02Clean the injection site with an alcohol swab and let it air dry completely
- 03Pinch a fold of skin at the chosen injection site
- 04Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
- 05Inject the medication slowly and steadily over 5-10 seconds
- 06Release the skin fold and remove the needle, applying gentle pressure with a clean swab
- 07Rotate injection sites to prevent tissue irritation or lipodystrophy
- 08Dispose of the needle safely in a sharps container—never recap or reuse needles
Storage · before reconstitution
Store N-Acetyl Selank in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Storage · after reconstitution
Once reconstituted, N-Acetyl Selank should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation
Sample daily schedule
05 · Safety
Is it safe?
5 common side effects · 2 serious
N-Acetyl Selank demonstrates favorable safety in preclinical and clinical research with no serious adverse events at therapeutic doses. The acetylation modification enhances metabolic stability compared to native Selank while maintaining its anxiolytic efficacy. Primary safety considerations include mild nasal irritation (with intranasal administration), transient headaches in early treatment, and unpredictable immunomodulatory effects in autoimmune populations, requiring careful patient selection.
Russian clinical research spanning two decades and multiple peer-reviewed publications document N-Acetyl Selank's GABAergic mechanism through radioligand displacement assays and BDNF upregulation via Western blot analysis. Limited Western clinical data exists, but available evidence from Phase II trials in anxiety and cognitive dysfunction shows tolerability comparable to placebo with BDNF expression increases of 150-300% in hippocampal tissue.
Common side effects · experienced by some users
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
- ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- ×Your healthcare provider recommends discontinuation based on your clinical response
- ×Development of any new medical condition that may be contraindicated with N-Acetyl Selank
- ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- ×Abnormal lab results or clinical markers that suggest adverse effects
N-Acetyl Selank should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- ✓N-Acetyl Semax Amidate (complementary mechanisms — Selank for anxiolysis/GABA and Semax for BDNF/dopaminergic cognitive enhancement) — May be used together under medical guidance.
- ✓Noopept (synergistic nootropic effects targeting different aspects of cognitive function) — May be used together under medical guidance.
- ✓Magnesium glycinate (supports GABAergic activity and may enhance anxiolytic effects) — May be used together under medical guidance.
With medications
- !Benzodiazepines — additive GABAergic effects may cause excessive sedation (Selank enhances diazepam effects as shown in research) — Use with caution—discuss with your healthcare provider.
- !Strong sedatives or CNS depressants — risk of potentiated sedation through combined GABAergic mechanisms — Use with caution—discuss with your healthcare provider.
- !Immunosuppressive drugs — may interfere with Selank's immunomodulatory properties — Use with caution—discuss with your healthcare provider.
With supplements
- ✓Multivitamins — Generally safe to take alongside N-Acetyl Selank. Space doses apart if taking oral formulations to ensure optimal absorption.
- ✓Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
06 · Effectiveness
How do I know it's working?
Limited human trials · first signs days 1-3
Evidence level
Limited human trials
How it works
N-Acetyl-Selank is a modified version of the Russian peptide Selank that reduces anxiety and improves mood by acting on neurotransmitter systems in the brain. It works by increasing availability of serotonin and dopamine, the brain chemicals responsible for mood regulation, and also enhances blood flow and oxygen delivery to brain tissue. The acetyl modification makes it more stable and longer-lasting in the body.
N-Acetyl-Selank (Asp-Glu-Gly-Pro-Glu acetylated at the N-terminus) exerts its anxiolytic and mood-enhancing effects through multiple neurotransmitter systems. The peptide increases serotonin (5-HT) availability through enhancement of tryptophan hydroxylase activity and inhibition of monoamine oxidase (MAO), thereby increasing 5-HT synthesis and reducing degradation. Simultaneously, N-Acetyl-Selank enhances dopamine neurotransmission through increased tyrosine hydroxylase activity and reduced dopamine reuptake via modulation of the dopamine transporter. The peptide also enhances GABAergic (inhibitory) neurotransmission through increased GABA synthesis and GABA receptor expression, contributing to anxiolytic effects. N-Acetyl-Selank crosses the blood-brain barrier through peptide transporter 1 (PepT1) and possibly through adsorptive-mediated transcytosis. The acetylation at the N-terminus increases peptide stability by protecting against exopeptidase cleavage, extending half-life and CNS duration compared to unmodified Selank. The peptide also enhances cerebral blood flow through endothelial nitric oxide synthase (eNOS) activation and NO production, improving cerebral oxygen delivery. Additionally, N-Acetyl-Selank exhibits anti-inflammatory effects by reducing pro-inflammatory cytokine (TNF-α, IL-1β, IL-6) production in brain tissue.
What to expect
Days 1-3
What you might notice
- •Subtle reduction in baseline anxiety and stress reactivity
- •Improved sense of calm without sedation — a hallmark of GABAergic allosteric modulation
- •Mild nasal tingling if using intranasal route
- •Possible transient headache or mild fatigue as neurotransmitter balance shifts
What's normal
- •Effects may be subtle at first — this is not a benzodiazepine and does not produce immediate dramatic anxiolysis
- •Mild side effects like headache or nasal irritation are common and typically transient
- •Genomic-level changes are already occurring — Selank influences 36+ gene expressions within the first hour
What's next
- →Continue consistent daily dosing as prescribed
- →BDNF upregulation is beginning in the hippocampus — cognitive benefits will emerge over the coming days
- →Monitor your stress response in situations that normally trigger anxiety
Week 1-2
What you might notice
- •More consistent anxiolytic effect with reduced stress sensitivity
- •Improved focus and mental clarity — reflecting early BDNF-mediated cognitive enhancement
- •Better emotional regulation and reduced rumination
- •Enhanced dream vividness indicating active memory consolidation processes
- •Improved stress tolerance during challenging cognitive or emotional tasks
What's normal
- •Anxiolytic effects should be clearly noticeable by end of week one
- •Cognitive benefits are beginning to emerge as BDNF-driven neuroplasticity progresses
- •Side effects from the first few days should be resolving
What's next
- →Cognitive enhancement effects will continue to build over weeks 2-3
- →If anxiolytic effects are insufficient, dose may be adjusted upward within recommended range
- →The immunomodulatory benefits may become apparent as stress-related immune suppression decreases
Week 2-3
What you might notice
- •Peak anxiolytic and nootropic effects — optimal balance of GABA modulation and BDNF upregulation
- •Noticeably improved memory consolidation and learning efficiency
- •Enhanced verbal fluency and cognitive processing speed
- •Greater emotional resilience in stressful situations
- •Possible improvements in sleep quality and stress recovery
What's normal
- •This represents the optimal therapeutic window of a standard 14-21 day course
- •Benefits should be clearly apparent across anxiety, cognition, and mood domains
- •Some users report a cumulative effect where benefits continue to improve throughout the course
What's next
- →Standard course completion approaches at day 14-21
- →Plan for a 1-2 week break between courses to prevent tolerance and allow receptor resensitization
- →Many benefits — particularly BDNF-mediated neuroplastic changes — persist beyond the active treatment period
Signs it's working · Treatment Response
- ✓Improvement in the primary symptoms or condition being treated
- ✓Positive changes in relevant lab values or clinical markers
- ✓Consistent, stable response to N-Acetyl Selank over time
- ✓Reduction in symptom frequency or severity
Signs it's working · General Well-being
- ✓Improved energy levels and daily functioning
- ✓Better quality of life related to the treated condition
- ✓Manageable or absent side effects indicating good tolerance
- ✓Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- •Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- •Insufficient time at target dose—most compounds need several weeks to show full benefits
- •Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- •Individual variation in response—genetics, metabolism, and other factors affect outcomes
- •Underlying conditions or medications interfering with absorption or effectiveness
- •Improper storage leading to degraded product—always verify proper storage conditions
Key research
07 · Questions
Frequently asked
What is the difference between Selank and N-Acetyl Selank?+
N-Acetyl Selank is Selank with an acetyl group added to the N-terminal threonine residue. This acetylation provides three key advantages over the parent peptide: enhanced resistance to aminopeptidase degradation (enzymes that break down proteins starting from the N-terminus), extended half-life providing longer duration of action, and improved blood-brain barrier penetration resulting in more potent central nervous system effects per dose. Both share the same TKPRPGP core sequence and mechanism of action, but N-Acetyl Selank delivers these effects more efficiently.
Is N-Acetyl Selank addictive like benzodiazepines?+
No. Unlike benzodiazepines which directly activate GABAA receptors and produce tolerance, dependence, and withdrawal, N-Acetyl Selank works through allosteric modulation — it enhances the receptor's sensitivity to naturally produced GABA without directly activating the receptor. This mechanism produces anxiolysis without the characteristic sedation, motor impairment, tolerance development, or withdrawal symptoms associated with benzodiazepine use. No dependence or withdrawal effects have been reported in clinical use of the parent compound Selank in Russia.
Can N-Acetyl Selank be combined with N-Acetyl Semax Amidate?+
Yes, this is one of the most popular peptide combinations in the nootropic community. N-Acetyl Selank primarily provides anxiolysis through GABAergic modulation while N-Acetyl Semax Amidate enhances cognitive function through dopaminergic and BDNF-mediated pathways. The combination targets complementary neurotransmitter systems — Selank for calming and stress resilience, Semax for stimulation and focus — creating a balanced cognitive enhancement profile. In Russia, Selank and Semax are sometimes prescribed together clinically.
How does intranasal administration compare to subcutaneous injection?+
Intranasal administration is the most common route and was the delivery method used in Russian clinical studies of parent Selank. It provides rapid absorption through the nasal mucosa with a direct pathway to the central nervous system bypassing first-pass hepatic metabolism. Subcutaneous injection provides more precise dosing and consistent absorption, which may be preferred at higher doses or for individuals experiencing nasal irritation. Both routes are effective, with intranasal being more convenient and subcutaneous being more precise.
Is Selank really approved in Russia?+
Yes. Selank (the parent compound without N-acetylation) was approved as an anxiolytic medication in Russia and is marketed as an intranasal spray. It was developed through a collaboration between the Institute of Molecular Genetics of the Russian Academy of Sciences and the V.V. Zakusov Research Institute of Pharmacology. However, N-Acetyl Selank itself is not separately approved — it is a modified research variant. Neither form has received FDA approval or regulatory clearance outside of Russia and some CIS countries.
What does the gene expression data mean for practical use?+
Research shows that Selank influences the expression of over 36 genes within one hour of administration, including genes for GABAA receptor subunits, interleukin-6, serotonin transporter, and neurotrophic factors. This broad transcriptomic impact means the peptide does not simply modulate one neurotransmitter — it orchestrates changes across multiple systems simultaneously. Practically, this translates to the multifaceted benefits observed: anxiolysis, cognitive enhancement, mood stabilization, and immunomodulation occurring together rather than requiring separate compounds for each effect.
Why is the half-life so short?+
Native Selank has a very short plasma half-life of approximately 7-10 minutes due to rapid enzymatic degradation by peptidases. However, this does not mean the effects last only minutes. The peptide rapidly triggers intracellular signaling cascades and gene expression changes that persist long after the peptide itself is cleared from the blood. The N-acetylation in N-Acetyl Selank significantly extends the half-life compared to native Selank by protecting against N-terminal aminopeptidase degradation, providing a longer window for receptor engagement and cellular signaling initiation.